706 Shares in Veeva Systems Inc. $VEEV Acquired by Invictus Private Wealth LLC

Invictus Private Wealth LLC acquired a new position in Veeva Systems Inc. (NYSE:VEEV) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 706 shares of the technology company’s stock, valued at approximately $203,000.

Several other institutional investors have also recently bought and sold shares of the stock. TFB Advisors LLC raised its position in Veeva Systems by 1.2% in the 1st quarter. TFB Advisors LLC now owns 3,586 shares of the technology company’s stock worth $831,000 after purchasing an additional 44 shares during the last quarter. Triangle Securities Wealth Management raised its position in Veeva Systems by 0.8% in the 2nd quarter. Triangle Securities Wealth Management now owns 5,782 shares of the technology company’s stock worth $1,665,000 after purchasing an additional 45 shares during the last quarter. Marks Group Wealth Management Inc raised its position in shares of Veeva Systems by 3.3% during the 1st quarter. Marks Group Wealth Management Inc now owns 1,427 shares of the technology company’s stock valued at $331,000 after acquiring an additional 46 shares during the last quarter. Harbour Investments Inc. raised its position in shares of Veeva Systems by 7.6% during the 1st quarter. Harbour Investments Inc. now owns 789 shares of the technology company’s stock valued at $183,000 after acquiring an additional 56 shares during the last quarter. Finally, Parallel Advisors LLC raised its position in shares of Veeva Systems by 4.7% during the 2nd quarter. Parallel Advisors LLC now owns 1,236 shares of the technology company’s stock valued at $356,000 after acquiring an additional 56 shares during the last quarter. Institutional investors own 88.20% of the company’s stock.

Analyst Upgrades and Downgrades

VEEV has been the subject of several recent research reports. TD Cowen upgraded shares of Veeva Systems from a “hold” rating to a “buy” rating and upped their target price for the company from $297.00 to $380.00 in a research report on Tuesday. Oppenheimer reiterated an “outperform” rating and set a $325.00 target price on shares of Veeva Systems in a research report on Thursday, August 28th. Raymond James Financial reiterated an “outperform” rating and set a $340.00 target price (up previously from $310.00) on shares of Veeva Systems in a research report on Thursday, August 28th. Evercore ISI upped their target price on shares of Veeva Systems from $285.00 to $295.00 and gave the company an “in-line” rating in a research report on Thursday, August 28th. Finally, Truist Financial upped their target price on shares of Veeva Systems from $268.00 to $275.00 and gave the company a “hold” rating in a research report on Thursday, August 28th. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $307.58.

Veeva Systems Stock Down 3.8%

Shares of VEEV stock opened at $287.04 on Friday. Veeva Systems Inc. has a 12-month low of $201.54 and a 12-month high of $310.50. The firm has a market capitalization of $47.05 billion, a price-to-earnings ratio of 58.94, a price-to-earnings-growth ratio of 2.31 and a beta of 0.98. The firm has a fifty day moving average of $282.91 and a 200-day moving average of $264.86.

Veeva Systems (NYSE:VEEV) last announced its quarterly earnings results on Wednesday, August 27th. The technology company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.90 by ($0.64). Veeva Systems had a net margin of 27.29% and a return on equity of 13.72%. The firm had revenue of $789.08 million during the quarter, compared to analyst estimates of $768.49 million. During the same period last year, the firm earned $1.62 EPS. Veeva Systems’s quarterly revenue was up 16.7% on a year-over-year basis. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. Research analysts expect that Veeva Systems Inc. will post 4.35 earnings per share for the current year.

Insider Buying and Selling

In related news, SVP Jonathan Faddis sold 14,595 shares of the company’s stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $300.00, for a total value of $4,378,500.00. Following the completion of the transaction, the senior vice president directly owned 8,588 shares of the company’s stock, valued at approximately $2,576,400. This represents a 62.96% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Eleni Nitsa Zuppas sold 6,000 shares of the company’s stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $306.62, for a total transaction of $1,839,720.00. Following the completion of the transaction, the insider directly owned 25,325 shares of the company’s stock, valued at approximately $7,765,151.50. The trade was a 19.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 24,665 shares of company stock valued at $7,438,000. Company insiders own 10.30% of the company’s stock.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.